Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × ziconotide × 1 year × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Interventions

pembrolizumab 594 Cyclophosphamide 543 Magnetic Resonance Spectroscopy 507 Radiotherapy 501 Specimen Handling 482 Nivolumab 419 Carboplatin 363 Cisplatin 358 Blood Specimen Collection 295 Biopsy 294 Radiosurgery 285 Paclitaxel 277 Dexamethasone 268 Standard of Care 266 Gemcitabine 263 venetoclax 262 Surveys and Questionnaires 260 Drug Therapy 260 fludarabine 250 Bevacizumab 241 Oxaliplatin 208 Rituximab 203 Fluorouracil 198 Ipilimumab 194 Capecitabine 194 Radiation 190 durvalumab 181 Doxorubicin 174 atezolizumab 169 Etoposide 165

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07499882 2026-03-30

Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy

Christian Hospital Northeast Northwest

Not yet recruiting

Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡